Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Aptamer Group Share News (APTA)
APTA Share
Price
APTA Share
News
APTA Share
Chat
APTA Share
Trades6
APTA
Live RNS
APTA Share
Charts
APTA Level 2
Console
APTA Live
Share Price
APTA Broker
Ratings
APTA Directors
Deals
APTA Financial
Diary
APTA
Fundamentals
APTA Short
Positions
APTA
Media
APTA Company
Research
APTA Company
Timeline
Share Price Information for Aptamer Group (APTA)
Last checked at -
Last checked at 
Intraday Aptamer Group Share Chart
Aptamer reports decent technical, commercial progress
(Sharecast News) - Aptamer Group reported solid progress on both the technical and commercial fronts on Friday as it held its annual general meeting.
The AIM-traded firm said that since its recapitalisation in August, it had undergone a cost reduction initiative, streamlining production processes to boost capacity, and decreased material requirements from customers.
It also continued to expand and convert its commercial pipeline, with a recent partnership involving a genetic medicines company to advance Optimer development, facilitating targeted delivery of new medicines.
At 1121 GMT, shares in Aptamer Group were down 2.5% at 1.17p.
Reporting by Josh White for Sharecast.com.
Latest APTA News
- EARNINGS AND TRADING: Capital Metals loss widens; Aptamer's contract
18 Aug 2025 - Aptamer secures contract extension with 'top five global pharma' partner
18 Aug 2025 - EARNINGS AND TRADING: Inspecs revenue dented by tariff uncertainty
1 Aug 2025 - TRADING UPDATES: Aptamer gets more Unilever work; Creo "confident"
21 Jul 2025 - Aptamer gets more commissioned work from Unilever
21 Jul 2025 - UK shareholder meetings calendar - next 7 days
17 Jul 2025 - Aptamer raises £2m to support expanding its Optimer technology
4 Jul 2025 - IN BRIEF: Aptamer raises GBP2 million for Optimer commercialisation
4 Jul 2025
Related News
WINNERS & LOSERS: Diales earnings rise; Mirriad warns of liquidation
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday.
TRADING UPDATES: LPA to meet consensus; Aptamer raises GBP4.28 million
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Thursday and not separately reported by Alliance News...
EARNINGS AND TRADING: Pennpetro eyes Texas well restart as oil rises
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...
Aptamer Group News
EARNINGS AND TRADING: Capital Metals loss widens; Aptamer's contract
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported...
Aptamer secures contract extension with 'top five global pharma' partner
(Sharecast News) - Biotechnology firm Aptamer said on Monday that it has secured an extension and new work order with a "top five global pharma partne...
EARNINGS AND TRADING: Inspecs revenue dented by tariff uncertainty
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not sep...
TRADING UPDATES: Aptamer gets more Unilever work; Creo "confident"
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:
Aptamer gets more commissioned work from Unilever
(Sharecast News) - Aptamer Group announced on Monday that it has received additional commissioned work from Unilever to support the ongoing developmen...
Aptamer raises £2m to support expanding its Optimer technology
(Sharecast News) - Aptamer Group announced on Friday that it has raised £2m through a placing of new shares to support the commercial expansion o...
IN BRIEF: Aptamer raises GBP2 million for Optimer commercialisation
Aptamer Group PLC - York, England-based biotechnology firm that provides Optimer binders for use in therapeutics, diagnostics, bioprocessing and resea...
Follow the stocks
